1. Home
  2. TITN vs PRTA Comparison

TITN vs PRTA Comparison

Compare TITN & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan Machinery Inc.

TITN

Titan Machinery Inc.

N/A

Current Price

$18.39

Market Cap

443.9M

ML Signal

N/A

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

N/A

Current Price

$9.12

Market Cap

449.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TITN
PRTA
Founded
1980
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
443.9M
449.7M
IPO Year
2007
2013

Fundamental Metrics

Financial Performance
Metric
TITN
PRTA
Price
$18.39
$9.12
Analyst Decision
Hold
Buy
Analyst Count
3
9
Target Price
$19.00
$19.00
AVG Volume (30 Days)
153.8K
539.6K
Earning Date
05-21-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$2,427,107,000.00
$814,000.00
Revenue This Year
N/A
$1,111.38
Revenue Next Year
$3.75
N/A
P/E Ratio
N/A
$35.04
Revenue Growth
N/A
N/A
52 Week Low
$13.21
$7.58
52 Week High
$25.00
$11.80

Technical Indicators

Market Signals
Indicator
TITN
PRTA
Relative Strength Index (RSI) 45.58 57.27
Support Level $17.24 $8.91
Resistance Level $20.46 $9.13
Average True Range (ATR) 0.86 0.41
MACD 0.03 0.09
Stochastic Oscillator 45.22 94.87

Price Performance

Historical Comparison
TITN
PRTA

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

Share on Social Networks: